Regulation of Down Syndrome Critical Region 1 expression by Nuclear Factor of Activated T cells in megakaryocytesKYTTÄLÄ, Satu; HABERMANN, Ivonne; MINAMI, Takashi et al.British journal of haematology. 2009, Vol 144, Num 3, pp 395-408, issn 0007-1048, 14 p.Article

T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantationSCHETELIG, Johannes; KIANI, Alexander; SCHMITZ, Marc et al.Cancer immunology and immunotherapy. 2005, Vol 54, Num 11, pp 1043-1058, issn 0340-7004, 16 p.Article

Gemtuzumab Ozogamicin as Part of Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed Acute Myeloid LeukemiaBORNHÄUSER, Martin; ILLMER, Thomas; PLATZBECKER, Uwe et al.Clinical cancer research (Print). 2008, Vol 14, Num 17, pp 5585-5593, issn 1078-0432, 9 p.Article

Normal intrinsic Th1/Th2 balance in patients with chronic phase chronic myeloid leukemia not treated with interferon-α or imatinibKIANI, Alexander; HABERMANN, Ivonne; SCHÄKEL, Knut et al.Haematologica (Roma). 2003, Vol 88, Num 7, pp 754-761, issn 0390-6078, 8 p.Article

Osteomyelosclerosis, anemia and extramedullary hematopoiesis in mice lacking the transcription factor NFATc2BAUER, Wolfgang; RAUNER, Martina; HAASE, Michael et al.Haematologica (Roma). 2011, Vol 96, Num 11, pp 1580-1588, issn 0390-6078, 9 p.Article

Prophylactic transfer of BCR-ABL―, PR1-, and WT1-reactive donor T cells after T cell―depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemiaBORNHÄUSER, Martin; THIEDE, Christian; WERMKE, Martin et al.Blood. 2011, Vol 117, Num 26, pp 7174-7184, issn 0006-4971, 11 p.Article

Pharmacokinetics of gemcitabine in a patient with end-stage renal disease: effective clearance of its main metabolite by standard hemodialysis treatmentKIANI, Alexander; KÖHNE, Claus-Henning; FRANZ, Thorsten et al.Cancer chemotherapy and pharmacology. 2003, Vol 51, Num 3, pp 266-270, issn 0344-5704, 5 p.Article

Minimal residual disease-directed preemptive treatment with azacitidine in patients with NPM1-mutant acute myeloid leukemia and molecular relapseSOCKEL, Katja; WERMKE, Martin; RADKE, Jörgen et al.Haematologica (Roma). 2011, Vol 96, Num 10, pp 1568-1570, issn 0390-6078, 3 p.Article

¹⁸⁸Re anti-CD66 radioimmunotherapy combined with reduced-intensity conditioning and in-vivo T cell depletion in elderly patients undergoing allogeneic haematopoietic cell transplantationLAUTER, Anett; STRUMPF, Annette; KOTZERKE, Jorg et al.British journal of haematology. 2010, Vol 148, Num 6, pp 910-917, issn 0007-1048, 8 p.Article

Regulation of interferon-γ gene expression by nuclear factor of activated T cellsKIANI, Alexander; GARCIA-COZAR, Francisco J; HABERMANN, Ivonne et al.Blood. 2001, Vol 98, Num 5, pp 1480-1488, issn 0006-4971Article

Regulation of fas-fas ligand-mediated apoptosis by nuclear factor of activated T cells in megakaryocytesARABANIAN, Laleh S; KUJAWSKI, Satu; HABERMANN, Ivonne et al.British journal of haematology. 2012, Vol 156, Num 4, pp 523-534, issn 0007-1048, 12 p.Article

Monitoring of donor chimerism in sorted CD34⁺ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantationBORNHÄUSER, Martin; OELSCHLAEGEL, Uta; THEUSER, Catrin et al.Haematologica (Roma). 2009, Vol 94, Num 11, pp 1613-1617, issn 0390-6078, 5 p.Article